Yoshihiro et al. reported that administration of a COX-2 inhibitor in SAS-LM3 tumor-bearing mice (an OSCC xenograft model) suppressed lymphangiogenesis and lymphatic metastasis [51]. The gene discussed is PTGS2; the disease is neoplasm.